133 related articles for article (PubMed ID: 9356339)
21. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.
Fukuda K; Vishnuvardhan D; Sekiya S; Hwang J; Kakiuchi N; Taira K; Shimotohno K; Kumar PK; Nishikawa S
Eur J Biochem; 2000 Jun; 267(12):3685-94. PubMed ID: 10848986
[TBL] [Abstract][Full Text] [Related]
22. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
Liu D; Wang YS; Gesell JJ; Wyss DF
J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
[TBL] [Abstract][Full Text] [Related]
23. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
24. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3.
Manabe S; Fuke I; Tanishita O; Kaji C; Gomi Y; Yoshida S; Mori C; Takamizawa A; Yosida I; Okayama H
Virology; 1994 Feb; 198(2):636-44. PubMed ID: 8291245
[TBL] [Abstract][Full Text] [Related]
25. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
26. Critical point mutations for hepatitis C virus NS3 proteinase.
Yamada K; Mori A; Seki M; Kimura J; Yuasa S; Matsuura Y; Miyamura T
Virology; 1998 Jun; 246(1):104-12. PubMed ID: 9656998
[TBL] [Abstract][Full Text] [Related]
27. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
28. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
Hamill P; Jean F
Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
[TBL] [Abstract][Full Text] [Related]
30. Isolation of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2007; (51):393-4. PubMed ID: 18029752
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
Locatelli GA; Gosselin G; Spadari S; Maga G
J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
[TBL] [Abstract][Full Text] [Related]
32. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
33. Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities.
Utama A; Shimizu H; Hasebe F; Morita K; Igarashi A; Shoji I; Matsuura Y; Hatsu M; Takamizawa K; Hagiwara A; Miyamura T
Virology; 2000 Aug; 273(2):316-24. PubMed ID: 10915602
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A.
Yamashita T; Unno H; Mori Y; Tani H; Moriishi K; Takamizawa A; Agoh M; Tsukihara T; Matsuura Y
Virology; 2008 Apr; 373(2):426-36. PubMed ID: 18201743
[TBL] [Abstract][Full Text] [Related]
35. Internal processing of hepatitis C virus NS3 protein.
Shoji I; Suzuki T; Sato M; Aizaki H; Chiba T; Matsuura Y; Miyamura T
Virology; 1999 Feb; 254(2):315-23. PubMed ID: 9986797
[TBL] [Abstract][Full Text] [Related]
36. Analysis of aptamer binding site for HCV-NS3 protease by alanine scanning mutagenesis.
Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Taira K; Kusakabe I; Nishikawa S
Nucleic Acids Symp Ser; 2000; (44):253-4. PubMed ID: 12903364
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
[TBL] [Abstract][Full Text] [Related]
38. Molecular models of NS3 protease variants of the Hepatitis C virus.
da Silveira NJ; Arcuri HA; Bonalumi CE; de Souza FP; Mello IM; Rahal P; Pinho JR; de Azevedo WF
BMC Struct Biol; 2005 Jan; 5():1. PubMed ID: 15663787
[TBL] [Abstract][Full Text] [Related]
39. In vitro selection of RNA aptamers against the HCV NS3 helicase domain.
Nishikawa F; Funaji K; Fukuda K; Nishikawa S
Oligonucleotides; 2004; 14(2):114-29. PubMed ID: 15294075
[TBL] [Abstract][Full Text] [Related]
40. Isolation of RNA aptamers specific for the 3' X tail of HCV.
Fukuda K; Toyokawa Y; Kikuchi K; Konno K; Ishihara R; Fukazawa C; Nishikawa S; Hasegawa T
Nucleic Acids Symp Ser (Oxf); 2008; (52):205-6. PubMed ID: 18776325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]